Are We Ready for Psychedelics? | Rachel Yehuda | 2026 Aspen Ideas Festival @MountSinaiNYC
Are We Ready for Psychedelics? | Rachel Yehuda | 2026 Aspen Ideas Festival  @MountSinaiNYC
Uploaded July 2026 | Updated November 2026, 6 hours ago
Late-stage clinical trials suggest psychedelic-based therapies to treat anxiety and depression will soon be available by prescription. Pharmaceutical companies are investing heavily in research and the White House has directed the FDA to put them on a fast track for review. But the road from clinical testing to marketing to broad use will be bumpy as we learn more about how psychedelics affect the brain, regulators develop a framework for assessing their safety and effectiveness, insurers consider whether to cover them, and healthcare providers seek out specialized training to ensure their proper use.
Are We Ready for Psychedelics? | Rachel Yehuda | 2026 Aspen Ideas FestivalI Am a Mount Sinai Nurse | Eamon OGara, RNBuilding a Culture of Resilience | Dr. Sarah Wood | 2026 Aspen Ideas FestivalFighting Antibiotic Resistance Takes All of UsRadioterapia para el Tratamiento del Cáncer de Cabeza y Cuello (H&N Spanish CC)From Sick Care to Healthspan | Dr. Zahi Fayad | Aspen Ideas FestivalHERology | The Healthy PregnancyBeyond the Badge - July 18, 2025Welcome to HERologyBeyond the Badge - June 6, 2025HERology | Postpartum Depression and Psychosis: What Every Mother Should KnowThe Carolyn Rowan Center for Women’s Health and Wellness on Good Day New York
Mount Sinai Health System |

Are We Ready for Psychedelics? | Rachel Yehuda | 2026 Aspen Ideas Festival

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER